Health

The pharmaceutical company's Social Impact Venture Capital Portfolio helps improve healthcare access for black and other minority groups in the US.

CVC advice includes: Do your homework on the business, don't go crazy on your projections and be honest about the competition.

Electric and semi-autonomous cars require increasingly sophisticated chips.

The California-based startup is taking on chip industry incumbents with the backing of carmakers like Denso and Mercedes-Benz.

Oil and gas companies backed just 32 startup deals with a total estimated value of $1.23 in the first quarter of the year.

Technology is starting to make it possible to understand the complex interactions of the microbiome in more detail.

BiomeSense, a University of Chicago spin out, wants to create a 10m record dataset for the microbiome sector.

Sometimes called the “last organ under active research”, the human microbiome and therapeutics relating to it are attracting dollars and interest in the innovation community – albeit still from a low base.

A treatment for all lung diseases, a rose petal-inspired coating to make solar cells more efficient and a device to resuscitate newborns are among this month's picks.

Data centres need a revamp to allow for the high-speed data processing artificial intelligence requires — and light is key to the transition.

GSK remains an investor in the new $600m Fund II, but with a smaller financial presence as SR One positions itself to connect startups to multiple companies across the pharmaceuticals sector.